Interferon-Mediated Response to Human Metapneumovirus Infection
Human metapneumovirus (HMPV) is one of the leading causes of respiratory diseases in infants and children worldwide. Although this pathogen infects mainly young children, elderly and immunocompromised people can be also seriously affected. To date, there is no commercial vaccine available against it...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/10/9/505 |
id |
doaj-75adb95180a446c8b1e0496db37050de |
---|---|
record_format |
Article |
spelling |
doaj-75adb95180a446c8b1e0496db37050de2020-11-24T21:38:51ZengMDPI AGViruses1999-49152018-09-0110950510.3390/v10090505v10090505Interferon-Mediated Response to Human Metapneumovirus InfectionIfeanyi K. Uche0Antonieta Guerrero-Plata1Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803, USADepartment of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803, USAHuman metapneumovirus (HMPV) is one of the leading causes of respiratory diseases in infants and children worldwide. Although this pathogen infects mainly young children, elderly and immunocompromised people can be also seriously affected. To date, there is no commercial vaccine available against it. Upon HMPV infection, the host innate arm of defense produces interferons (IFNs), which are critical for limiting HMPV replication. In this review, we offer an updated landscape of the HMPV mediated-IFN response in different models as well as some of the defense tactics employed by the virus to circumvent IFN response.http://www.mdpi.com/1999-4915/10/9/505human metapneumovirusHMPVinterferonIFNpneumovirusrespiratory |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ifeanyi K. Uche Antonieta Guerrero-Plata |
spellingShingle |
Ifeanyi K. Uche Antonieta Guerrero-Plata Interferon-Mediated Response to Human Metapneumovirus Infection Viruses human metapneumovirus HMPV interferon IFN pneumovirus respiratory |
author_facet |
Ifeanyi K. Uche Antonieta Guerrero-Plata |
author_sort |
Ifeanyi K. Uche |
title |
Interferon-Mediated Response to Human Metapneumovirus Infection |
title_short |
Interferon-Mediated Response to Human Metapneumovirus Infection |
title_full |
Interferon-Mediated Response to Human Metapneumovirus Infection |
title_fullStr |
Interferon-Mediated Response to Human Metapneumovirus Infection |
title_full_unstemmed |
Interferon-Mediated Response to Human Metapneumovirus Infection |
title_sort |
interferon-mediated response to human metapneumovirus infection |
publisher |
MDPI AG |
series |
Viruses |
issn |
1999-4915 |
publishDate |
2018-09-01 |
description |
Human metapneumovirus (HMPV) is one of the leading causes of respiratory diseases in infants and children worldwide. Although this pathogen infects mainly young children, elderly and immunocompromised people can be also seriously affected. To date, there is no commercial vaccine available against it. Upon HMPV infection, the host innate arm of defense produces interferons (IFNs), which are critical for limiting HMPV replication. In this review, we offer an updated landscape of the HMPV mediated-IFN response in different models as well as some of the defense tactics employed by the virus to circumvent IFN response. |
topic |
human metapneumovirus HMPV interferon IFN pneumovirus respiratory |
url |
http://www.mdpi.com/1999-4915/10/9/505 |
work_keys_str_mv |
AT ifeanyikuche interferonmediatedresponsetohumanmetapneumovirusinfection AT antonietaguerreroplata interferonmediatedresponsetohumanmetapneumovirusinfection |
_version_ |
1725934185204416512 |